Bruce Stroever - 17 Sep 2024 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BBLG	Non-Employee Stock Option	Award	$0	+30,713	$0.000000	30,713	17 Sep 2024	Common Stock	30,713	$1.73	Direct	F1
holding	BBLG	Non-Employee Stock Option					10,721	17 Sep 2024	Common Stock	10,721	$5.12	Direct	F2
holding	BBLG	Non-Employee Stock Option					154	17 Sep 2024	Common Stock	154	$387.26	Direct	F2
holding	BBLG	Non-Employee Stock Option					37	17 Sep 2024	Common Stock	37	$844.80	Direct	F2
holding	BBLG	Non-Employee Stock Option					13	17 Sep 2024	Common Stock	13	$1260.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable quarterly through the date of the next annual meeting of stockholders of the Company.
F2	This option is fully exercisable as of the date of this report.